Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.

Shape the future of ID with peers from around the world this October at IDWeek in Atlanta, Georgia! 

Register today ➡️ https://registration.experientevent.com/ShowIDS251

View the interactive program ➡️ https://idweek2025.eventscribe.net/